Janux Therapeutics, Inc. (NASDAQ:JANX) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and pre-funded warrants Closed: US$402.5M raised · US$63 a share · BofA Securities +8 Dealers: BofA Securities (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead), William Blair (co-lead), Wedbush PacGrow, LifeSci Capital, BTIG, Jones Use of proceeds: Advance clinical development of its internal product pipeline and general corporate purposes | Dec 6, 2024 |